Fonte: The Journal of Rheumatology. Unidades: FORP, FMRP
Assuntos: ARTRITE REUMATOIDE (EFEITOS DE DROGAS), METOTREXATO, ANTICORPOS MONOCLONAIS, EXPRESSÃO GÊNICA (ANÁLISE), GENES (CARACTERÍSTICAS)
ABNT
OLIVEIRA, Renê Donizeti Ribeiro et al. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy. The Journal of Rheumatology, v. 39, n. 8, p. 1524-1532, 2012Tradução . . Disponível em: https://doi.org/10.3899/jrheum.120092. Acesso em: 01 out. 2024.APA
Oliveira, R. D. R., Fontana, V., Junta, C. M., Marques, M. M. C., Macedo, C., Rassi, D. M., et al. (2012). Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy. The Journal of Rheumatology, 39( 8), 1524-1532. doi:10.3899/jrheum.120092NLM
Oliveira RDR, Fontana V, Junta CM, Marques MMC, Macedo C, Rassi DM, Passos GAS, Donadi EA, Louzada Junior P. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy [Internet]. The Journal of Rheumatology. 2012 ; 39( 8): 1524-1532.[citado 2024 out. 01 ] Available from: https://doi.org/10.3899/jrheum.120092Vancouver
Oliveira RDR, Fontana V, Junta CM, Marques MMC, Macedo C, Rassi DM, Passos GAS, Donadi EA, Louzada Junior P. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy [Internet]. The Journal of Rheumatology. 2012 ; 39( 8): 1524-1532.[citado 2024 out. 01 ] Available from: https://doi.org/10.3899/jrheum.120092